Literature DB >> 9063027

Interleukin-6 in hepatitis C cirrhosis.

M Malaguarnera1, B A Trovato, A Laurino, I Di Fazio, M A Romeo, M Motta.   

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine involved in numerous diseases but the correlation between liver fibrosis and IL-6 role is not clear. We studied IL-6 levels in 50 HCVAb+ patients with liver cirrhosis (grouped into A, B and C, Child classes) and in 27 healthy control subjects. IL-6 serum levels were significantly increased in the former (p < 0.005) suggesting that IL-6 stimulates and sustains liver fibrosis. In cirrhotic subjects, the rise in IL-6 serum levels is due to impaired hepatic clearance of this cytokine, while its production remains steady.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9063027

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  5 in total

1.  Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6.

Authors:  Banchob Sripa; Eimorn Mairiang; Bandit Thinkhamrop; Thewarach Laha; Sasithorn Kaewkes; Paiboon Sithithaworn; Smarn Tessana; Alex Loukas; Paul J Brindley; Jeffrey M Bethony
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

2.  Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.

Authors:  Abdel-Rahman N Zekri; Mohammed S El-Din Ashour; Ahmed Hassan; Hanaa M Alam El-Din; Amal M R El-Shehaby; Maha A Abu-Shady
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

3.  Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus.

Authors:  M Malaguarnera; I Di Fazio; M A Romeo; S Restuccia; A Laurino; B A Trovato
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

4.  High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.

Authors:  B Xu; U Broome; B-G Ericzon; S Sumitran-Holgersson
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

5.  The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.

Authors:  T Ezure; T Sakamoto; H Tsuji; J G Lunz; N Murase; J J Fung; A J Demetris
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.